Washington State Senators Advance Bill to Legalize Psilocybin Therapy
Washington State took a significant step toward creating a regulated framework for therapeutic psilocybin use this week.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
Washington State took a significant step toward creating a regulated framework for therapeutic psilocybin use this week.
Read More
Colorado regulators are reviewing rules that could add ibogaine to the state's Natural Medicine program -- making it the first to do so.
Read More
Millions of people continue to struggle with long COVID. Now, new research suggests psilocybin mushrooms may offer relief.
Read More
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read More
Researchers found that small doses of psilocybin can improve the originality, but not the amount, of creative ideas.
Read More
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More
Scientist captured the first detailed look at how 5-MeO-DMT reshapes brain activity which challenge long held assumptions.
Read More
Psilocybin has shown promise for treating depression, but its hallucinogenic effects create barriers. A new study may change that.
Read More
The findings add to growing evidence that psychedelics may treat conditions long resistant to conventional approaches.
Read More
The University of Texas Medical Branch just received a $50 million grant to study ibogaine, a plant based psychoactive compound.
Read More